Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions

Treatment of depression is hampered by the failure to identify distinct symptom profiles with distinct pathophysiologies that differentially respond to distinct treatments. We posit that inflammatory depression is a meaningful depression subtype associated with specific symptoms and biological abnor...

Full description

Bibliographic Details
Main Authors: Klara Suneson, Jesper Lindahl, Simon Chamli Hårsmar, Gustav Söderberg, Daniel Lindqvist
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/4/1640
_version_ 1797413840875421696
author Klara Suneson
Jesper Lindahl
Simon Chamli Hårsmar
Gustav Söderberg
Daniel Lindqvist
author_facet Klara Suneson
Jesper Lindahl
Simon Chamli Hårsmar
Gustav Söderberg
Daniel Lindqvist
author_sort Klara Suneson
collection DOAJ
description Treatment of depression is hampered by the failure to identify distinct symptom profiles with distinct pathophysiologies that differentially respond to distinct treatments. We posit that inflammatory depression is a meaningful depression subtype associated with specific symptoms and biological abnormalities. We review several upstream, potentially causative, mechanisms driving low-grade inflammation in this subtype of depression. We also discuss downstream mechanisms mediating the link between inflammation and symptoms of depression, including alterations in dopaminergic neurotransmission and tryptophan metabolism. Finally, we review evidence for several non-pharmacological interventions for inflammatory depression, including probiotics, omega-3 fatty acids, and physical exercise interventions. While some evidence suggests that these interventions may be efficacious in inflammatory depression, future clinical trials should consider enriching patient populations for inflammatory markers, or stratify patients by inflammatory status, to confirm or refute this hypothesis.
first_indexed 2024-03-09T05:23:49Z
format Article
id doaj.art-ee767399ba7249bead66fa0d891005fa
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T05:23:49Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ee767399ba7249bead66fa0d891005fa2023-12-03T12:38:31ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-02-01224164010.3390/ijms22041640Inflammatory Depression—Mechanisms and Non-Pharmacological InterventionsKlara Suneson0Jesper Lindahl1Simon Chamli Hårsmar2Gustav Söderberg3Daniel Lindqvist4Department of Clinical Sciences Lund, Psychiatry, Faculty of Medicine, Lund University, 221 85 Lund, SwedenDepartment of Clinical Sciences Lund, Psychiatry, Faculty of Medicine, Lund University, 221 85 Lund, SwedenOffice for Psychiatry and Habilitation, Psychiatric Clinic Lund, Region Skåne, 221 85 Lund, SwedenDepartment of Clinical Sciences Lund, Psychiatry, Faculty of Medicine, Lund University, 221 85 Lund, SwedenDepartment of Clinical Sciences Lund, Psychiatry, Faculty of Medicine, Lund University, 221 85 Lund, SwedenTreatment of depression is hampered by the failure to identify distinct symptom profiles with distinct pathophysiologies that differentially respond to distinct treatments. We posit that inflammatory depression is a meaningful depression subtype associated with specific symptoms and biological abnormalities. We review several upstream, potentially causative, mechanisms driving low-grade inflammation in this subtype of depression. We also discuss downstream mechanisms mediating the link between inflammation and symptoms of depression, including alterations in dopaminergic neurotransmission and tryptophan metabolism. Finally, we review evidence for several non-pharmacological interventions for inflammatory depression, including probiotics, omega-3 fatty acids, and physical exercise interventions. While some evidence suggests that these interventions may be efficacious in inflammatory depression, future clinical trials should consider enriching patient populations for inflammatory markers, or stratify patients by inflammatory status, to confirm or refute this hypothesis.https://www.mdpi.com/1422-0067/22/4/1640depressioninflammationdysbiosisn-3 PUFAsexercise
spellingShingle Klara Suneson
Jesper Lindahl
Simon Chamli Hårsmar
Gustav Söderberg
Daniel Lindqvist
Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
International Journal of Molecular Sciences
depression
inflammation
dysbiosis
n-3 PUFAs
exercise
title Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
title_full Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
title_fullStr Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
title_full_unstemmed Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
title_short Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
title_sort inflammatory depression mechanisms and non pharmacological interventions
topic depression
inflammation
dysbiosis
n-3 PUFAs
exercise
url https://www.mdpi.com/1422-0067/22/4/1640
work_keys_str_mv AT klarasuneson inflammatorydepressionmechanismsandnonpharmacologicalinterventions
AT jesperlindahl inflammatorydepressionmechanismsandnonpharmacologicalinterventions
AT simonchamliharsmar inflammatorydepressionmechanismsandnonpharmacologicalinterventions
AT gustavsoderberg inflammatorydepressionmechanismsandnonpharmacologicalinterventions
AT daniellindqvist inflammatorydepressionmechanismsandnonpharmacologicalinterventions